Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting
Brain Pathology · 15.07.2026
DOI: 10.1111/bpa.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 15.07.2026. Verfasst von Katrin Mauch-Mücke und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutschen Konsortium für Translationale Krebsforschung, Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe), Deutsche Krebshilfe.
Abstract (Originalsprache)
BeadChip array‐based DNA methylation profiling has been recognized by the World Health Organization (WHO) as a key diagnostic tool for brain tumor classification. While its diagnostic utility has been well established, data on technical reproducibility, interlaboratory comparability, and data interpretation under real‐world diagnostic conditions remain limited. Bridging this gap, we here report the results of an international proficiency test using the Infinium MethylationEPIC v2.0 platform and the corresponding Brain Tumor Classifier version 12.8. Tissue slides of eight FFPE brain tumor samples, covering a representative range of CNS tumor entities, were distributed among 24 laboratories in 10 different countries. Participants were asked to report methylation classes and copy number variation (CNV) profiles. Pre‐array workflows were left to local procedures and results had to be submitted within 15 working days. Technical data reproducibility was high with a median pairwise beta‐value correlation of 0.99 (range 0.93–1.0). In general, participating centers generated high‐quality data, reflected by consistently low detection p ‐values (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
- Bavarian Cancer Research Center (BZKF), Regensburg, Germany.
- Department of Neuropathology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Quality in Pathology (QuIP GmbH), Berlin, Germany.
- Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Neuropathology, University of Giessen, Giessen, Germany.
ORCID-Profile: Alonso Barrantes-Freer, Bérengère Dadone-Montaudié, Daniel Erny, Patrick N Harter, Linea Melchior, Julia E Neumann, Nicole Pfarr, Laveniya Satgunaseelan, Felix Sahm
Förderung
- Deutschen Konsortium für Translationale Krebsforschung
- Mildred Scheel Career Center Frankfurt (Deutsche Krebshilfe)
- Deutsche Krebshilfe
Zitieren
APA
Mauch-Mücke, K., Siewert, C., Dimitrova, L., Pohl, S., Osberg, B., Wefers, A. K., Lorenz, J., Rothhammer-Hampl, T., Acker, T., Barrantes-Freer, A., Boutonnat, J., Dadone-Montaudié, B., Delbridge, C., Dietmaier, W., Dintner, S., Dohmen, H., Dottermusch, M., Erny, D., Frauenknecht, K. B. M., …, & Capper, D. (2026). Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting. Brain Pathology. https://doi.org/10.1111/bpa.70121
Vancouver
Mauch-Mücke K, Siewert C, Dimitrova L, Pohl S, Osberg B, Wefers AK, et al. Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting. Brain Pathology. 2026. doi:10.1111/bpa.70121
BibTeX
@article{MauchMcke2026,
author = {Mauch-Mücke, Katrin and Siewert, Christin and Dimitrova, Lora and Pohl, Sandra and Osberg, Brendan and Wefers, Annika K and Lorenz, Julia and Rothhammer-Hampl, Tanja and Acker, Till and Barrantes-Freer, Alonso and Boutonnat, Jean and Dadone-Montaudié, Bérengère and Delbridge, Claire and Dietmaier, Wolfgang and Dintner, Sebastian and Dohmen, Hildegard and Dottermusch, Matthias and Erny, Daniel and Frauenknecht, Katrin B M and Goschzik, Tobias and Harter, Patrick N and Hirsch, Daniela and Hou, Yanghao and Kraus, Theo F J and Lee, Maggie and Liesche-Starnecker, Friederike and Leer, Anne Mc and Melchior, Linea and Mittelbronn, Michael and Müller, Wolf C and Nair, Shalima S and Neumann, Julia E and Niehusmann, Pitt and Pfarr, Nicole and Pietsch, Torsten and Prinz, Marco and Rechsteiner, Markus and Reimann, Regina and Satgunaseelan, Laveniya and Skarpeteig, Veronica and Skjulsvik, Anne J and Sotlar, Karl and Vanden Bempt, Isabelle and Vassella, Erik and Weber, Katharina J and Wasinger, Gabriel and Waha, Andreas and Zwaenepoel, Karen and Sahm, Felix and Riemenschneider, Markus J and Capper, David},
title = {Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reporting},
journal = {Brain Pathology},
year = {2026},
doi = {10.1111/bpa.70121}
}
EUVIMED